CANDA, T. Et Al. 2018. Immunohistochemical HER2 Status Evaluation in Breast Cancer Pathology Samples: A Multicenter, Parallel-Design Concordance Study. EUROPEAN JOURNAL OF BREAST HEALTH , vol.14, no.3 , 160-165.

CANDA, T., Yavuz, E., ÖZDEMİR, N., Ilvan, S., Dizbay, S. S., Durak, M. G., ... Tuzlali, S.(2018). Immunohistochemical HER2 Status Evaluation in Breast Cancer Pathology Samples: A Multicenter, Parallel-Design Concordance Study. EUROPEAN JOURNAL OF BREAST HEALTH , vol.14, no.3, 160-165.

CANDA, TÜLAY Et Al. "Immunohistochemical HER2 Status Evaluation in Breast Cancer Pathology Samples: A Multicenter, Parallel-Design Concordance Study," EUROPEAN JOURNAL OF BREAST HEALTH , vol.14, no.3, 160-165, 2018

CANDA, TÜLAY Et Al. "Immunohistochemical HER2 Status Evaluation in Breast Cancer Pathology Samples: A Multicenter, Parallel-Design Concordance Study." EUROPEAN JOURNAL OF BREAST HEALTH , vol.14, no.3, pp.160-165, 2018

CANDA, T. Et Al. (2018) . "Immunohistochemical HER2 Status Evaluation in Breast Cancer Pathology Samples: A Multicenter, Parallel-Design Concordance Study." EUROPEAN JOURNAL OF BREAST HEALTH , vol.14, no.3, pp.160-165.

@article{article, author={TÜLAY CANDA Et Al. }, title={Immunohistochemical HER2 Status Evaluation in Breast Cancer Pathology Samples: A Multicenter, Parallel-Design Concordance Study}, journal={EUROPEAN JOURNAL OF BREAST HEALTH}, year=2018, pages={160-165} }